USPSTF recommends aspirin for prevention of colorectal cancer
the ONA take:
For the first time, the United States Preventive Services Task Force (USPSTF) has issued a broad recommendation to take aspirin to prevent colorectal cancer.
In the draft report, the task force found that low-dose or baby aspirin can help prevent heart attacks, stroke, and colorectal cancer, particularly in high-risk people in their 50’s.
An analysis on colorectal cancer found that aspirin use reduced colorectal cancer-related deaths by 33% and reduced colon cancer incidence by 40%; however, people need to take aspirin for at least 5 to 10 years in order to have a benefit.
“No major health organization has previously recommended the use of aspirin to prevent cancer,” Dr. Eric Jacobs of the American Cancer Society said. “This is a new approach that makes a great deal of sense.”
However, not everyone feels positively about these new recommendations. “People still need to be screened,” Dr. David Johnson of the United Stated Multi-Society Task Force on Colorectal Cancer said. “I have major reservations that the message will be, ‘I take aspirin, so I don’t need to be screened.’”
According to the American Cancer Society, colorectal cancer is the third leading cause of cancer-related deaths in the United States in men and women separately and the second leading cause when combined.
The USPSTF has issued a broad recommendation to take aspirin to prevent colorectal cancer.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|